HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides

Tools

Mathieu, M.G., Knights, A.J., Pawelec, G., Riley, C.L., Wernet, D., Lemonnier, F.A., Straten, P.T., Mueller, L., Rees, R.C. ORCID: 0000-0002-4574-4746 and McArdle, S.E. ORCID: 0000-0001-6929-9782, 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Cancer Immunology Immunotherapy
Creators:	Mathieu, M.G., Knights, A.J., Pawelec, G., Riley, C.L., Wernet, D., Lemonnier, F.A., Straten, P.T., Mueller, L., Rees, R.C. and McArdle, S.E.
Date:	2007
Volume:	56
Number:	12
ISSN:	0340-7004
Divisions:	Schools > School of Science and Technology
Record created by:	EPrints Services
Date Added:	09 Oct 2015 10:27
Last Modified:	24 Nov 2021 14:23
URI:	https://irep.ntu.ac.uk/id/eprint/13151